Glenmede Trust’s National Research Corp Class B NRCIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-287
Closed -$11K 2930
2017
Q2
$11K Hold
287
﹤0.01% 2100
2017
Q1
$11K Hold
287
﹤0.01% 2100
2016
Q4
$11K Hold
287
﹤0.01% 2094
2016
Q3
$10K Sell
287
-250
-47% -$8.45K ﹤0.01% 2143
2016
Q2
$17K Sell
537
-25
-4% -$920 ﹤0.01% 1952
2016
Q1
$19K Hold
562
﹤0.01% 1846
2015
Q4
$20K Hold
562
﹤0.01% 1878
2015
Q3
$18K Buy
562
+300
+115% +$9.93K ﹤0.01% 1936
2015
Q2
$8K Hold
262
﹤0.01% 2156
2015
Q1
$8K Hold
262
﹤0.01% 2179
2014
Q4
$9K Hold
262
﹤0.01% 2237
2014
Q3
$9K Sell
262
-100
-28% -$3.88K ﹤0.01% 2147
2014
Q2
$14K Buy
362
+50
+16% +$2.07K ﹤0.01% 1969
2014
Q1
$13K Hold
312
﹤0.01% 1998
2013
Q4
$10K Sell
312
-25
-7% -$800 ﹤0.01% 1997
2013
Q3
$10K Hold
337
﹤0.01% 1936
2013
Q2
$11K Buy
+337
New +$11.9K ﹤0.01% 1860

Other funds holding NRCIB

Glenmede Trust's NRCIB Position: Q3 2017 in Review

Glenmede Trust sold out of National Research Corp Class B (NRCIB) in Q3 2017, closing a stake of 287 shares — an estimated $11K sold.

Glenmede Trust first reported a position in NRCIB in Q2 2013 and held it in 17 quarters. The position peaked at $20K in Q4 2015. 26 funds tracked by Wall St. Rank hold NRCIB as of Q3 2017.

  • Glenmede Trust reported no remaining National Research Corp Class B position as of Q3 2017 after selling out during the quarter.
  • Glenmede Trust sold 287 National Research Corp Class B shares in Q3 2017, an estimated $11K.
  • Glenmede Trust first reported a position in National Research Corp Class B in Q2 2013 and held it in 17 quarters.
  • Glenmede Trust's National Research Corp Class B position peaked at $20K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held National Research Corp Class B as of Q3 2017.

Based on Glenmede Trust's 13F filing for Q3 2017, filed 14 Nov 2017.